Bone regeneration in cranial defects previously treated with radiation

Area of Science:

• Regenerative Medicine
• Tissue Engineering
• Orthopedic Surgery

Background:

• Head and neck bone reconstruction often follows radiation therapy.
• Previous studies show osteoinductive protein therapy alone is insufficient for healing radiated bone defects.
• Tissue engineering approaches require validation in radiated bone environments.

Purpose of the Study:

• To evaluate the efficacy of ex vivo gene therapy with bone morphogenetic protein-7 (BMP-7) for healing critical-sized calvarial defects in rats.
• To determine if ex vivo gene therapy can overcome impaired bone healing caused by preoperative radiation.
• To assess the impact of radiation on BMP-7 gene therapy-mediated bone regeneration.

Main Methods:

• Fisher rats were subjected to either no radiation or a 12 Gray radiation dose to the calvarium.
• Syngeneic dermal fibroblasts were transduced ex vivo with an adenoviral vector encoding BMP-7.
• Critical-sized calvarial defects were created and treated with either a cell-seeded scaffold or an autologous bone graft.
• Defects were harvested at 4 or 8 weeks post-surgery for gross and histologic evaluation.

Main Results:

• Autologous bone grafts showed no healing in radiated defects.
• Nonradiated defects treated with BMP-7 gene therapy achieved near-complete bone regeneration within 4 weeks.
• Radiated defects treated with gene therapy exhibited incomplete healing with mixed soft tissue and bone islands at 4 and 8 weeks, indicating ongoing endochondral ossification.

Conclusions:

• Preoperative radiation significantly hinders the effectiveness of BMP-7 ex vivo gene therapy in healing critical-sized cranial defects in rats.
• These findings suggest challenges in applying this tissue engineering strategy to patients with radiation-compromised bone defects, particularly in cancer treatment contexts.
• Further research is needed to optimize gene therapy approaches for bone regeneration in irradiated tissues.